TickerStat.comwe like data

Creo Medical Group plc (CREO)

Price£0.12875Cached quote
CREOLondon Stock Exchange
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue£6.0M£4.0M£4.0M£27.2M
Operating expenses£21.9M£30.7M£29.2M£43.9M
Operating income−£19.5M−£28.8M−£26.9M−£30.7M
Operating margin−325.00%−720.00%−672.50%−112.87%
EBITDA−£16.2M−£26.1M−£22.8M−£27.5M
EBITDA margin−270.00%−652.50%−570.00%−101.10%
Net income£5.3M−£28.7M−£21.7M−£26.9M
Net profit margin88.33%−717.50%−542.50%−98.90%
Basic EPSper basic share£0.01-£0.08-£0.07-£0.14
Diluted EPSper diluted share£0.01-£0.08-£0.07-£0.14
Review official market source ↗

Owners

Reported major voting-rights holders

FCA threshold notices
M&G Plc · 12.02% of voting rightsLiontrust Investment Partners LLP · 7.29% of voting rightsDevelopment Bank of Wales PLC · 2.92% of voting rights
12.02%of voting rights
M&G PlcNotified Sep 11, 2025
View holders
Reported major voting-rights holders of CREO
HolderVoting rights
M&G Plc
12.02%Sep 11, 2025 · 49.58M votes
Liontrust Investment Partners LLP
7.29%Jul 31, 2026 · 32.72M votes
Development Bank of Wales PLC
2.92%May 28, 2026 · 13.13M votes

These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.

Gray completes the 100% scale; it is not an estimate of other owners.

Source: FCA National Storage Mechanism ↗Updated Oct 21, 2026

Community posts

View community